139 related articles for article (PubMed ID: 11893198)
1. Asymmetric total synthesis of (+)-fostriecin.
Reddy YK; Falck JR
Org Lett; 2002 Mar; 4(6):969-71. PubMed ID: 11893198
[TBL] [Abstract][Full Text] [Related]
2. Versatile enantiocontrolled synthesis of (+)-fostriecin.
Esumi T; Okamoto N; Hatakeyama S
Chem Commun (Camb); 2002 Dec; (24):3042-3. PubMed ID: 12536807
[TBL] [Abstract][Full Text] [Related]
3. Catalyst-controlled asymmetric synthesis of fostriecin and 8-epi-fostriecin.
Maki K; Motoki R; Fujii K; Kanai M; Kobayashi T; Tamura S; Shibasaki M
J Am Chem Soc; 2005 Dec; 127(48):17111-7. PubMed ID: 16316259
[TBL] [Abstract][Full Text] [Related]
4. Fundamental role of the fostriecin unsaturated lactone and implications for selective protein phosphatase inhibition.
Buck SB; Hardouin C; Ichikawa S; Soenen DR; Gauss CM; Hwang I; Swingle MR; Bonness KM; Honkanen RE; Boger DL
J Am Chem Soc; 2003 Dec; 125(51):15694-5. PubMed ID: 14677930
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and( beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors.
Swingle MR; Amable L; Lawhorn BG; Buck SB; Burke CP; Ratti P; Fischer KL; Boger DL; Honkanen RE
J Pharmacol Exp Ther; 2009 Oct; 331(1):45-53. PubMed ID: 19592665
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of the C1-C12 fragment of fostriecin.
Cossy J; Pradaux F; BouzBouz S
Org Lett; 2001 Jul; 3(14):2233-5. PubMed ID: 11440587
[TBL] [Abstract][Full Text] [Related]
7. Fostriecin: chemistry and biology.
Lewy DS; Gauss CM; Soenen DR; Boger DL
Curr Med Chem; 2002 Nov; 9(22):2005-32. PubMed ID: 12369868
[TBL] [Abstract][Full Text] [Related]
8. Total synthesis and evaluation of cytostatin, its C10-C11 diastereomers, and additional key analogues: impact on PP2A inhibition.
Lawhorn BG; Boga SB; Wolkenberg SE; Colby DA; Gauss CM; Swingle MR; Amable L; Honkanen RE; Boger DL
J Am Chem Soc; 2006 Dec; 128(51):16720-32. PubMed ID: 17177422
[TBL] [Abstract][Full Text] [Related]
9. Total synthesis of fostriecin (CI-920) via a convergent route.
Miyashita K; Ikejiri M; Kawasaki H; Maemura S; Imanishi T
Chem Commun (Camb); 2002 Apr; (7):742-3. PubMed ID: 12119701
[TBL] [Abstract][Full Text] [Related]
10. Total synthesis and biological evaluation of the protein phosphatase 2A inhibitor cytostatin and analogues.
Bialy L; Waldmann H
Chemistry; 2004 Jun; 10(11):2759-80. PubMed ID: 15195307
[TBL] [Abstract][Full Text] [Related]
11. Enantio- and stereoselective route to the phoslactomycin family of antibiotics: formal synthesis of (+)-fostriecin and (+)-phoslactomycin B.
Sarkar SM; Wanzala EN; Shibahara S; Takahashi K; Ishihara J; Hatakeyama S
Chem Commun (Camb); 2009 Oct; (39):5907-9. PubMed ID: 19787137
[TBL] [Abstract][Full Text] [Related]
12. Formal total synthesis of fostriecin.
Wang YG; Kobayashi Y
Org Lett; 2002 Dec; 4(26):4615-8. PubMed ID: 12489943
[TBL] [Abstract][Full Text] [Related]
13. Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.
McCluskey A; Sim AT; Sakoff JA
J Med Chem; 2002 Mar; 45(6):1151-75. PubMed ID: 11881984
[No Abstract] [Full Text] [Related]
14. Total synthesis of fostriecin: via a regio- and stereoselective polyene hydration, oxidation, and hydroboration sequence.
Gao D; O'Doherty GA
Org Lett; 2010 Sep; 12(17):3752-5. PubMed ID: 20687585
[TBL] [Abstract][Full Text] [Related]
15. Fostriecin, an inhibitor of protein phosphatase 2A, limits myocardial infarct size even when administered after onset of ischemia.
Weinbrenner C; Baines CP; Liu GS; Armstrong SC; Ganote CE; Walsh AH; Honkanen RE; Cohen MV; Downey JM
Circulation; 1998 Sep; 98(9):899-905. PubMed ID: 9738645
[TBL] [Abstract][Full Text] [Related]
16. Total synthesis of an antitumor antibiotic, Fostriecin (CI-920).
Miyashita K; Ikejiri M; Kawasaki H; Maemura S; Imanishi T
J Am Chem Soc; 2003 Jul; 125(27):8238-43. PubMed ID: 12837094
[TBL] [Abstract][Full Text] [Related]
17. Dinuclear asymmetric Zn aldol additions: formal asymmetric synthesis of fostriecin.
Trost BM; Frederiksen MU; Papillon JP; Harrington PE; Shin S; Shireman BT
J Am Chem Soc; 2005 Mar; 127(11):3666-7. PubMed ID: 15771479
[TBL] [Abstract][Full Text] [Related]
18. The predicted beta12-beta13 loop is important for inhibition of PP2Acalpha by the antitumor drug fostriecin.
Evans DR; Simon JA
FEBS Lett; 2001 Jun; 498(1):110-5. PubMed ID: 11389908
[TBL] [Abstract][Full Text] [Related]
19. Total synthesis of fostriecin (CI-920).
Boger DL; Ichikawa S; Zhong W
J Am Chem Soc; 2001 May; 123(18):4161-7. PubMed ID: 11457179
[TBL] [Abstract][Full Text] [Related]
20. Purification of protein phosphatase 4 catalytic subunit: inhibition by the antitumour drug fostriecin and other tumour suppressors and promoters.
Hastie CJ; Cohen PT
FEBS Lett; 1998 Jul; 431(3):357-61. PubMed ID: 9714542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
